IPEM topical report: current molecular radiotherapy service provision and guidance on the implications of setting up a dosimetry service. (11th December 2020)

• Record Type: Journal Article
• Authors: Craig, Allison J; Rojas, Bruno; Wevrett, Jill L; Hamer, Elaine; Fenwick, Andrew; Gregory, Rebecca
• Is Part Of: Physics in medicine & biology. Volume 65:Number 24(2020:Dec.)
• Publication Date: 2020-12-11
• Subjects: dosimetry -- molecular radiotherapy -- radionuclide therapy; Biophysics -- Periodicals; Medical physics -- Periodicals; 610.153
• DOI: 10.1088/1361-6560/abc707
• Languages: English
• ISSNs: 0031-9155

Abstract

Abstract: Despite a growth in molecular radiotherapy treatment (MRT) and an increase in interest, centres still rarely perform MRT dosimetry. The aims of this report were to assess the main reasons why centres are not performing MRT dosimetry and provide advice on the resources required to set-up such a service. A survey based in the United Kingdom was developed to establish how many centres provide an MRT dosimetry service and the main reasons why it is not commonly performed. Twenty-eight per cent of the centres who responded to the survey performed some form of dosimetry, with 88% of those centres performing internal dosimetry. The survey showed that a 'lack of clinical evidence', a 'lack of guidelines' and 'not current UK practice' were the largest obstacles to setting up an MRT dosimetry service. More practical considerations, such as 'lack of software' and 'lack of staff training/expertise', were considered to be of lower significance by the respondents. Following on from the survey, this report gives an overview of the current guidelines, and the evidence available demonstrating the benefits of performing MRT dosimetry. The resources required to perform such techniques are detailed with reference to guidelines, training resources and currently available software. It is hoped that the information presented in this report will allow MRT dosimetry to be performed more frequently and in more centres, both in routine clinical practice and in multicentre trials. Such trials are required to harmonise dosimetry techniques between centres, build on the current evidence base, and provide the data necessary to establish the dose–response relationship for MRT.